Active, Not Recruiting
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma
NCT05252429
- Conditions
- Effect of Drug, Head and Neck Neoplasms, Neoplasms, +1 more
- Locations
-
- Hokkaido University Hospital Sapporo, Hokkaido, Japan